FLT3 antibody

Synonyms:CD135 antibody, FLK2 antibody, STK1 antibody
Catalogue No.:FNab03164Reactivity:Human, Mouse, Rat
Host:RabbitTested Application:ELISA, WB, IP
Clonality:polyclonalIsotype:IgG
  • SPECIFICATIONS
Product Name
FLT3 antibody
Catalogue No.
FNab03164
Size
100μg
Form
liquid
Purification
Immunogen affinity purified
Purity
≥95% as determined by SDS-PAGE
Clonality
polyclonal
Isotype
IgG
Storage
PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20℃ for 12 months(Avoid repeated freeze / thaw cycles.)
Immunogen
Immunogen
fms-related tyrosine kinase 3
Alternative Names
CD135 antibody, FLK2 antibody, STK1 antibody
UniProt ID
P36888
Observed MW
130-140 kDa
Application
Tested Applications
ELISA, WB, IP
Recommended dilution
WB: 1:500-1:2000; IP: 1:200-1:2000
Validated Images
mouse brain tissue were subjected to SDS PAGE followed by western blot with FNab03164(FLT3 antibody) at dilution of 1:500
IP Result of anti-FLT3 (IP:FNab03164, 4ug; Detection:FNab03164 1:500) with mouse brain tissue lysate 2640ug.
Background
Tyrosine-protein kinase that acts as cell-surface receptor for the cytokine FLT3LG and regulates differentiation, proliferation and survival of hematopoietic progenitor cells and of dendritic cells. Promotes phosphorylation of SHC1 and AKT1, and activation of the downstream effector MTOR. Promotes activation of RAS signaling and phosphorylation of downstream kinases, including MAPK1/ERK2 and/or MAPK3/ERK1. Promotes phosphorylation of FES, FER, PTPN6/SHP, PTPN11/SHP-2, PLCG1, and STAT5A and/or STAT5B. Activation of wild-type FLT3 causes only marginal activation of STAT5A or STAT5B. Mutations that cause constitutive kinase activity promote cell proliferation and resistance to apoptosis via the activation of multiple signaling pathways.